Akron Bio

11/08/2023

No te pierdas esta conferencia sobre mujeres en biotecnología.

Realizaremos un recorrido de aprendizaje con mapa y brújula, y hablaremos de barreras y oportunidades junto a Claudia Zylberberg, fundadora de y experta en medicina regenerativa y terapias avanzadas.

🗓️ lunes 13 de noviembre
⏰ 17:30 horas
📍Centro de Extensión PUC Alameda #390, Santiago (Metro Estación Universidad Católica) - Sala 203
🚨Actividad gratuita

04/12/2022

04/08/2022

It’s happening ! Excited to share the news and the new site.

03/08/2022

At Akron Bio, we celebrate the achievements of women across the world who continue to inspire, empower and support those around them.

02/23/2022

Join us today at 11:30 GMT to listen to Akron’s Dr. Sara Padrell speak at the Next Gen CAR-TCR Summit about Akron’s latest developments and the launch of our new Closed System Solutions™ product line. For more information, visit: https://next-generation-cartcr.com

02/17/2022

Join Akron’s Dr. Sara Padrell at the Next Gen CAR-TCR Summit in London from February 22-24. Sara will be introducing Akron’s new line of Closed System Solutions™ and discussing how Akron’s innovative design can improve the cell and gene therapy manufacturing processes.

02/16/2022

A look at the key processing steps for the safety of Akron’s virus inactivated AB serum converted from Octaplas®, ranging from donor virus screening to aseptic fill of AR1010. By leveraging Octaplas®, Akron offers a high-quality product with excellent batch-to-batch consistency and a proven safety profile.
Contact us to learn more: https://akronbiotech.com/contact-us

02/09/2022

Manufacture your cell therapies using a proven safe and reliable human serum. Learn more about Akron’s virus inactivated AB serum converted from Octaplas®: https://akronbiotech.com/product/human-ab-serum

01/31/2022

Through immune neutralization, Akron’s virus inactivated AB serum converted from Octaplas® has validated virus reduction of critical non-enveloped viruses including HAV and B19V. Immune neutralization combined with solvent detergent treatment to address enveloped viruses delivers a product with a proven safety profile.

Read more about the power of immune neutralization: https://akronbiotech.com/blog/enhancing-the-safety-of-virus-inactivated-ancillary-materials-through-neutralizing-antibodies

01/26/2022

Phacilitate’s Advanced Therapies Week has officially kicked off! Stop by booth 223 to meet the Akron Bio team to learn more about our products and services.